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Abstract
Osterix (Osx or Sp7) is a zinc-finger-family transcriptional factor essential for osteoblast differentiation in mammals. The Osx-
Cre mouse line (also known as Osx1-GFP::Cre) expresses GFP::Cre fusion protein from a BAC transgene containing the Osx
regulatory sequence. The mouse strain was initially characterized during embryogenesis, and found to target mainly
osteoblast-lineage cells. Because the strain has been increasingly used in postnatal studies, it is important to evaluate its
targeting specificity in mice after birth. By crossing the Osx-Cre mouse with the R26-mT/mG reporter line and analyzing the
progenies at two months of age, we find that Osx-Cre targets not only osteoblasts, osteocytes and hypertrophic
chondrocytes as expected, but also stromal cells, adipocytes and perivascular cells in the bone marrow. The targeting of
adipocytes and perivascular cells appears to be specific to those residing within the bone marrow, as the same cell types
elsewhere are not targeted. Beyond the skeleton, Osx-Cre also targets the olfactory glomerular cells, and a subset of the
gastric and intestinal epithelium. Thus, potential contributions from the non-osteoblast-lineage cells should be considered
when Osx-Cre is used to study gene functions in postnatal mice.
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Introduction
Osterix (Osx or Sp7) is a zinc finger family transcriptional factor
critical for osteoblast differentiation[1]. During embryonic skeletal
development, Osx is initially expressed in the perichondrium
flanking the hypertrophic cartilage, where osteoblasts first arise to
produce the bone collar (cortical bone). Later during development,
the perichondrial Osx-expressing osteoprogenitors co-migrate with
the blood vessels that invade the hypertrophic cartilage, and to
generate osteoblasts responsible for depositing the trabecular bone
[2,3]. In addition, Osx is also detected in early hypertrophic
chondrocytes at a relatively weak level [4]. Genetic studies have
revealed the essential role of Osx in osteoblast differentiation[5]. In
Osx-null embryos, cartilage elements are largely normal but
osteoblast differentiation fails to complete, resulting in a complete
lack of bone tissue [1]. In these embryos, Runx2 expression is
relatively normal, but other osteoblast markers including Col1a1,
Bsp, and osteocalcin are either absent or severely suppressed [1]. On
the other hand, the expression of Osx is abolished in Runx2-null
embryos[1]. Thus, Osx functions genetically downstream of Runx2
to control osteoblast differentiation[6]. In addition to its role in
embryonic osteoblast differentiation, Osx also plays a critical role in
the formation and function of postnatal osteoblast and osteocyte [7].
The Cre/loxP technology enables gene deletion in specific cell
types and has significantly advanced our understanding of gene
functions in both physiological and pathological conditions. In this
system, specificity is achieved by expression of the Cre recombi-
nase under the control of cell type-specific regulatory sequences.
Osx-Cre (Osx1-GFP::Cre), a BAC transgenic mouse line expressing a
GFP::Cre fusion protein from the regulatory sequence of Osx, was
generated to direct gene deletion in the osteoblast lineage [8]. The
initial characterization of this mouse line revealed that Cre activity
is largely restricted to the osteogenic perichondrium, periosteum
and osteoblast-lineage cells within the marrow cavity, but that
analysis was limited to the embryo [8]. Although in recent years
the Osx-Cre mouse line has been increasingly used to study the
osteoblast lineage in postnatal mice [9,10,11,12,13], the targeting
specificity of Osx-Cre in postnatal bones is yet to be formally
evaluated.
Here we assess the cell types targeted by Osx-Cre in two-month-
old mice by monitoring GFP expression from the R26-mT/mG
reporter allele. The R26-mT/mG allele ubiquitously expresses a
membrane-targeted red fluorescent protein (mTomato) but
switches to expressing a membrane-targeted green fluorescent
protein (mGFP) upon Cre recombination. We find that within the
skeleton, Osx-Cre targets not only osteoblast lineage cells and a
subset of chondrocytes, but also stromal cells, adipocytes and
perivascular cells specifically within the bone marrow. Moreover,




Osx-Cre (Osx1-GFP::Cre) and R26-mT/mG mouse lines are as
previously described [8,14]. All mouse procedures used in this
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study were approved by the Animal Studies Committee at
Washington University.
Cryostat sections
Two-month-old mice were perfused with 4% PFA as described
previously[15]. After perfusion, tibias were dissected and fixed in
4% PFA at 4uC overnight. The fixed tibias were decalcified in
14% EDTA for 3 days and then snap-frozen in OCT embedding
medium. Frozen sections were cut at 8 mm thickness with a
cryostat equipped with Cryojane (Leica, IL). The sections were
kept at 220uC until analyses.
Figure 1. Osx-Cre targets osteoblast lineage cells, hypertrophic chondrocytes and bone marrow stromal cells. (A–B) Confocal images
for direct fluorescence from EGFP (A, B) or EGFP/tdTomato (A9, B9) on longitudinal tibial sections from two-month-old R26-mT/mG (A, A9) or Osx-Cre;
R26-mT/mGmice (B, B9); 1: chondro-osseous junction of primary ossification center; 2: secondary ossification center. (C–F, C9–F9) Higher magnification
images for EGFP (C–F) or EGFP/tdTomato: trabecular bone (C, C9), cortical bone (D, D9), growth plate (E, E9) and bone marrow (F, F9). Red: membrane-
targeted tdTomato; Green: membrane-targeted EGFP; Blue: DAPI. Arrow: osteocyte.
doi:10.1371/journal.pone.0085161.g001
Figure 2. Osx-Cre marks adipocytes in bone marrow. (A–B) Double immunostaining for EGFP (A) and perilipin (B) on longitudinal sections of
tibias from two-month-old Osx-Cre; R26-mT/mG mice. (C) Co-localization of EGFP and perilipin. Arrows denote co-expression of GFP and perilipin.
Green: EGFP; magenta: perilipin; blue: DAPI.
doi:10.1371/journal.pone.0085161.g002
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Figure 3. Osx-Cre does not mark non-bone marrow adipocytes. (A–B) Images for direct fluorescence from tdTomato (A) or EGFP (B) in whole-
mount gonadal fat depots from two-month-old Osx-Cre; R26-mT/mG mice. (C–F) Direct fluorescence for tdTomato (C) and immunofluorescence for
perilipin (D) and EGFP (E) on sections of gonadal fat depots from two-month-old Osx-Cre;R26-mT/mG mice. (G–K) Imaging of longitudinal sections of
an intramuscular fat depot associated with a tibia from two-month-old Osx-Cre;R26-mT/mG mice. G: perilipin immunofluorescence; H: EGFP
immunofluorescence; I: direct fluorescence for tdTomato; J: merged view of G–I; K: DAPI staining. Arrow: GFP-positive periosteum.
doi:10.1371/journal.pone.0085161.g003
Figure 4. Osx-Cre marks perivascular smooth muscle cells in bone marrow. (A–C) Confocal images of EGFP (A), tdTomato (B), and aSMA (C)
on longitudinal sections of tibias from two-month-old Osx-Cre; R26-mT/mG mice. (D–F) Merged images. Arrow: co-expression of EGFP and aSMA.
EGFP and aSMA: immunofluorescence; tdTomato: direct fluorescence. DAPI stains DNA blue.
doi:10.1371/journal.pone.0085161.g004
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Immunofluorescence staining
For detection of GFP, perilipin or aSMA, immunostaining was
performed on cryostat sections using a chicken polyclonal GFP
antibody (1:2500; Abcam, Cambridge, MA), or rabbit monoclonal
perilipin antibody (1:100; Cell Signaling Technology, Danvers,
MA), or mouse monoclonal aSMA antibody (1:500, Sigma, St.
Louis, MO). The secondary antibodies are as follows: Alexa
FluorH 488 Goat Anti-Chicken IgG (for GFP); Alexa FluorH 647
F(ab’)2 Fragment of Goat Anti-Rabbit IgG (for perilipin), and
Alexa FluorH 647 Goat Anti-Mouse IgG2a (for aSMA) (all at
1:250, Life Technologies, Grand Island, NY). Sections were
mounted with VECTASHIELD Mounting Medium containing
DAPI (VECTOR LABORATORIES, Burlingame, CA).
Quantitative analyses
All quantitative data were obtained from three independent
animals. Statistical analyses were performed with student’s t-test.
Results
Osx-Cre targets osteoblasts, osteocytes, bone marrow
stromal cells and hypertrophic chondrocytes
To characterize the targeting specificity of Osx-Cre in postnatal
mouse bones, we generated Osx-Cre; R26-mT/mG mice (one copy
each of Osx-Cre and R26-mT/mG) and analyzed GFP expression
on sections of long bones at two months of age. As expected, bone
sections from the control R26-mT/mG mice did not exhibit any
GFP (Fig. 1A, A9), but those from Osx-Cre; R26-mT/mG mice
contained many GFP-positive cells (Fig. 1B, B9). Consistent with
the targeting of osteoblast-lineage cells, many GFP-positive cells
were present at both primary and secondary ossification centers, as
well as the cortical bone surfaces (Fig. 1B, B9). Examination at a
higher magnification revealed that essentially all cells associated
with the trabecular, endosteal and periosteal surfaces, as well as
most osteocytes were GFP-positive (Fig. 1C, C9, D, D9). Moreover,
a large population of bone marrow stromal cells expressed GFP
(Fig. 1F, F9). These cells exhibited a reticular morphology and
were readily distinguishable from the hematopoietic population.
Finally, GFP was detected in some prehypertrophic and hyper-
trophic chondrocytes within the growth plate (Fig. 1E, E9),
consistent with previous reports of endogenous Osx expression in
these cells [16]. Thus, in addition to osteoblasts and osteocytes,
Osx-Cre also targets the bone marrow stromal cells and the growth
plate hypertrophic chondrocytes in postnatal mice.
Osx-Cre targets adipocytes specifically in the bone
marrow
Within the bone marrow, in addition to the reticular stromal
cells, we also detected other GFP-positive cells that appeared to be
adipocytes. To confirm this observation, we performed double
immunofluorescence experiments with antibodies against GFP
and the adipocyte-specific marker perilipin. Indeed, on bone
sections from the Osx-Cre; R26-mT/mG mice, more than 90% of
the perilipin-positive adipocytes present within the bone marrow
also stained for GFP (Fig. 2). To determine whether Osx-Cre also
targets adipocytes outside the bone marrow, we examined the
whole-mount gonadal fat depot from Osx-Cre; R26-mT/mG mice
under a fluorescence microscope but didn’t detect any GFP
(Fig. 3A–B). Double immunostaining of sections from the gonadal
fat depot confirmed that the perilipin-positive adipocytes were
GFP-negative (Fig. 3C–F). Similarly, adipose tissues adjacent to
the periosteum and associated with the skeletal muscle did not
express GFP (Fig.3G–J). Thus, Osx-Cre effectively targets adipo-
cytes specifically within the bone marrow environment.
Osx-Cre targets perivascular cells specifically in the bone
marrow
Our initial examination of the long bone sections revealed that
certain GFP-positive cells appeared to associate directly with blood
vessels. To confirm the identity of these cells as perivascular
smooth muscle cells, we performed double immunofluorescence
experiments with antibodies against GFP and aSMA. Direct
visualization of tdTomato under a fluorescence microscope
revealed that the endothelial cells expressed a strong signal,
whereas the aSMA-positive cells were immediately adjacent to the
endothelial cells as expected (Fig. 4F). Importantly, in three Osx-
Cre; R26-mT/mG mice analyzed, nearly all aSMA-positive
perivascular smooth muscle cells co-expressed GFP (Fig. 4D)
(93.962.8%, n= 3), and 100% of the ten bone marrow blood
vessels observed were found to associate with GFP-positive cells. In
contrast, the blood vessels abundantly present in the gonadal
adipose tissue did not contain GFP-positive cells (Fig. 3C9, E9).
Thus, Osx-Cre targets a high percentage of the perivascular smooth
muscle cells specifically within the bone marrow.
Figure 5. Osx-Cre targets olfactory glomerular cells. (A–D) Direct
fluorescence of whole-mount rostral brain from a two-month-old Osx-
Cre; R26-mT/mG mouse. ob: olfactory bulb. (E–H) Direct fluorescence of
tdTomato (E, F) and EGFP (G, H) on sagittal sections through the
olfactory bulb of Osx-Cre (E, G) or Osx-Cre; R26-mT/mG (F, H) mice at two
months of age. GL: glomerular layer.
doi:10.1371/journal.pone.0085161.g005
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Osx-Cre targets cells beyond the skeleton
We next examined all tissues of the Osx-Cre; R26-mT/mG mouse
for potential targeting by Osx-Cre. We first ensured that no GFP
was detected in any of the organs of the control R26-mT/mG mice.
In Osx-Cre; R26-mT/mG mice, we found no GFP in liver, kidney,
pancreas, heart, lung, adrenal gland, thymus, thyroid or skeletal
muscle. Much of the brain was also negative, but the olfactory
bulb expressed strong GFP as evident from the ventral view of the
rostral brain (Fig. 5A–D). Sagittal sections through the bulb
revealed that Osx-Cre targeted essentially all cells of the glomerular
layer (Fig. 5E, F). In addition, a strong GFP signal was observed in
whole-mount samples of the stomach, small and large intestines
from Osx-Cre; R26-mT/mG but not R26-mT/mG littermates (Fig. 6
A–D, data not shown). Cross-section of the small intestine revealed
that GFP was non-uniformly expressed by enterocytes along the
villi, whereas cells in the crypts were largely negative (Fig. 6E–G).
Similarly, cross sections through the stomach indicated mosaic
GFP expression in the epithelium including parietal cells (Fig. 6
H–J). The precise identity of the targeted intestinal or gastric cells
was not further pursued in the present study.
Discussion
Osx-Cre and bone marrow mesenchymal stem cells
Evidence suggests that mesenchymal stem cells (MSCs) residing
within the adult bone marrow produce osteoblasts, adipocytes and
bone marrow stromal cells necessary for postnatal tissue homeo-
stasis [17,18]. Moreover, accumulating evidence supports that
mesenchymal stem cells reside within a perivascular niche
[18,19,20,21,22]. Our present work demonstrates that Osx-Cre
targets not only osteoblasts and osteocytes, but also the bone
marrow stromal cells and perivascular smooth muscle cells, even
though the later cell types do not actively express the GFP::Cre
protein. These results raise the possibility that Osx-Cre targets a
common progenitor of the aforementioned cell types, perhaps the
bone marrow MSC. Alternatively, Osx-Cre may mark a diverse
group of progenitors each producing a single mature cell type (e.g.,
stromal or perivascular cell). In either case, the progenitors do not
appear to continuously express Osx or Osx-Cre throughout
postnatal life, as cells actively expressing Osx postnatally, when
marked with Osx-CreER in response to tamoxifen, failed to sustain
the turnover of either osteoblasts or stromal cells [15,23]. Overall,
the current data support the model that embryonic Osx-expressing
cells give rise to the bone marrow mesenchymal progenitors in
postnatal mice. Additional experiments are necessary to test this
hypothesis formally.
Organ-specific origin of bone marrow adipocytes and
perivascular cells
Bone marrow adipose tissue is believed to be metabolically
different from non-marrow peripheral fat depots [24]. Our data
showed that bone marrow but not other adipocytes are derived
from Osx-lineage cells, indicating a distinct cell origin of the bone
marrow adipocytes. Similarly, perivascular smooth muscle cells
specifically associated with bone marrow but not other blood
vessels are derived from Osx-expressing progenitors. While this
work was in review, others using the Ai9 Cre reporter mouse
reported similar findings about the targeting of bone marrow
adipocytes and perivascular smooth muscle cells by Osx-Cre, thus
allaying the concern over limitations of a single Cre reporter [25].
Overall, these findings support the view that mesenchymal cell
types in different organs may be derived from organ-specific stem/
progenitor cells that reside locally.
Limitation of Osx-Cre as a tool for studying osteoblast
biology
Our data clearly indicate that Osx-Cre, when activated in the
embryo, targets more than osteoblast-lineage cells in postnatal
mice. These findings echo the increasing concern that many Cre
strains exhibit some degree of unintended recombination activity
[26]. Whereas the relationship between marrow fat and bone is
increasingly appreciated [24], the potential influence of stromal
cells and perivascular cells on bone is largely unknown. In
addition, Osx-Cre targets olfactory glomerular cells and the GI tract
epithelia. Targeting of the olfactory bulb is consistent with
endogenous Osx expression as previously reported in this organ
[27]. On the other hand, it is not clear at present whether Osx is
normally expressed in the GI tract, or the mosaic Cre activity
there simply reflects a phenomenon specific to the Osx-Cre
transgene. Furthermore, it is not known whether Osx-Cre-mediated
gene deletion in the olfactory bulb or the GI track affects bone
physiology. Nonetheless, caution needs to be taken when one
interprets postnatal bone phenotypes caused by gene deletion with
Osx-Cre beginning in the embryo.
Figure 6. Osx-Cre targets gastric and intestinal epithelia. (A–D)
Direct fluorescence of tdTomato (A, C) and EGFP (B, D) in whole-mount
small intestine of two-month-old R26-mT/mG (A, B) or Osx-Cre; R26-mT/
mG mice (C, D). (E–G) Direct fluorescence on cross sections of small
intestine from a two-month-old Osx-Cre; R26-mT/mG mouse. Red-
boxed area in F shown at a higher magnification in G. (H–J) Direct
fluorescence on stomach sections from a two-month-old Osx-Cre; R26-
mT/mG mouse. Red-boxed area in I shown at a higher magnification in
J. White arrow denotes parietal cells.
doi:10.1371/journal.pone.0085161.g006
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